FDA: “Extreme” Anti-Aging Claims Led To 2012 Warning Letters
This article was originally published in The Rose Sheet
Executive Summary
A proliferation of “extreme” anti-aging cosmetic claims that crossed the line into drug territory led to FDA’s cluster of warning letters in 2012, according to Jennifer Thomas, director of the division of enforcement in the Center for Food Safety and Applied Nutrition’s office of compliance,